24.03
-0.32
(-1.31%)
At close: April 17 at 8:01:43 AM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 19 | 18 | 22 | 24 |
Avg. Estimate | 3.58B | 3.62B | 14.28B | 14.97B |
Low Estimate | 3.51B | 3.52B | 13.97B | 14.21B |
High Estimate | 3.66B | 3.74B | 14.49B | 15.51B |
Year Ago Sales | 3.7B | 3.62B | 14.54B | 14.28B |
Sales Growth (year/est) | -3.21% | -0.07% | -1.79% | 4.85% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
CXR.F | -- | -- | -- | -- |
S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
Maintains | UBS: Buy to Buy | 4/17/2025 |
Reiterates | Raymond James: Outperform to Outperform | 4/17/2025 |
Maintains | RBC Capital: Sector Perform to Sector Perform | 4/17/2025 |
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 4/17/2025 |
Maintains | Barclays: Overweight to Overweight | 4/17/2025 |
Maintains | BMO Capital: Outperform to Outperform | 4/17/2025 |